NCT02675829 2026-03-04Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant CancersMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting131 enrolled
NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT05238831 2024-01-23SMMART Adaptive Clinical Treatment (ACT) TrialOHSU Knight Cancer InstitutePhase EARLY_PHASE1 Withdrawn